Clinical trial
A Two-stage,Multi-center,Open-label, Randomized,Controlled Trial Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis
NCT04222114 is registered in ClinicalTrials.gov with LintonPharm Co.,Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Two-stage,Multi-center,Open-label, Randomized,Controlled Trial Comparing the Efficacy and Safety of Intra-peritoneal Infusion of Catumaxomab and Treatment of Investigator Choice in Patients With Advanced Gastric Carcinoma With Peritoneal Metastasis
- Lead sponsor
- LintonPharm Co.,Ltd.
- Phase
- Phase 3
- Overall status
- Unknown status
- Start date
- October 6, 2020
- Completion date
- August 31, 2023
- Enrollment
- 282 (estimated)
- Sites
- 13
Conditions
As the registry lists them; a condition with its own page is linked.